Breaking News

MaaT Pharma, Skyepharma Finish Microbiome Ecosystem Therapies Facility

Facility designed to support MaaT Pharma’s clinical-and commercial-scale manufacturing of Microbiome Ecosystem Therapies.

Maat Pharma, a clinical-stage biotech company in the development of Microbiome Ecosystem Therapies (MET) dedicated to improving survival outcomes for patients with cancer, and Skyepharma, a contract development and manufacturing organization (CDMO), that provides innovative solutions for bioproduction as well as complex drugs development and manufacturing, reported that a significant development milestone has been reached with the completion of the 17,200 sq. ft. facility and the transfer of Maa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters